Target intelligence / Profile preview

Arterial blood vessels supplying the lesion

Molecular classification
Other (Anatomical structure)
01

Overview

Arterial blood vessels supplying the lesion refer to the specific vascular network responsible for delivering oxygenated blood and nutrients to a pathological area, such as a malignant tumor or a vascular malformation (National Cancer Institute, 2023). These vessels are frequently targeted in interventional radiology through procedures like transarterial chemoembolization (TACE) to induce localized ischemia and deliver therapeutic agents directly to the site of disease (Lencioni & Llovet, 2010, Radiology). While not a single molecular entity, these vessels represent a physiological target for mechanical or chemical occlusion to starve the lesion of its blood supply (StatPearls, 2023). In oncology, the recruitment of these vessels is often driven by pro-angiogenic factors like Vascular Endothelial Growth Factor (VEGF), making the vascular endothelial cells a secondary molecular target for systemic therapies (PubMed, PMID: 26438671). Precise identification of these feeding arteries is crucial to minimize damage to adjacent healthy tissues and prevent complications such as non-target embolization (Mayo Clinic, 2023).

Other names
Feeding arteriesTumor-feeding vesselsLesion-supplying vasculatureAfferent vessels
02

Mechanism of action

Mechanical occlusion of blood flow (embolization), chemical ablation, or inhibition of neoangiogenesis to induce ischemia and necrosis within the lesion (StatPearls, 2023; NIH, 2023).

03

Biological functions

Oxygen transport (NIH, 2023)Nutrient delivery (NIH, 2023)Waste removal (NIH, 2023)Thermoregulation (StatPearls, 2023)
04

Disease associations

Cancer (StatPearls, 2023)Arteriovenous malformation (Mayo Clinic, 2023)Uterine fibroids (StatPearls, 2023)Hemorrhage (StatPearls, 2023)
05

Safety considerations

Non-target embolization (Mayo Clinic, 2023)Tissue ischemia (StatPearls, 2023)Vessel perforation (StatPearls, 2023)Post-embolization syndrome (StatPearls, 2023)Infarction of healthy tissue (Mayo Clinic, 2023)
06

Interacting drugs

Polyvinyl alcohol (PVA) particles (StatPearls, 2023)

4 more in the full profile.

07

Biomarkers

Angiographic visualization (NIH, 2023)Computed tomography angiography (CTA) (Mayo Clinic, 2023)Magnetic resonance angiography (MRA) (Mayo Clinic, 2023)Vascular endothelial growth factor (VEGF) (PubMed, PMID: 26438671)

Beyond the preview

Go deeper on Arterial blood vessels supplying the lesion.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arterial blood vessels supplying the lesion.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call